Try our beta test site
3 studies found for:    "thanatophoric dysplasia"
Show Display Options
Rank Status Study
1 Recruiting Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 Melitis
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: INGAP Peptide, Ustekinumab
2 Completed Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
Condition: Hypoglycemia
Interventions: Drug: ZP4207;   Drug: GlucaGen
3 Unknown  An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Td5ap;   Biological: Td1aP

Study has passed its completion date and status has not been verified in more than two years.